Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
V.íctor G. Dávila-Román, MD, FACC*
,*,
Giridhar Vedala, MD*
,
Pilar Herrero, MS
,
Lisa de las Fuentes, MD*
,
Joseph G. Rogers, MD, FACC
,
Daniel P. Kelly, MD, FACC
and
Robert J. Gropler, MD, FACC
* Cardiovascular Imaging and Clinical Research Core Laboratory, Washington University School of Medicine, St. Louis, Missouri, USA
Cardiovascular Division, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA
Center for Cardiovascular Research, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA
Cardiovascular Imaging Laboratory, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA

View larger version (24K):
[in a new window]
|
Figure 1 Positron emission tomography (PET) imaging protocol to assess myocardial metabolism. After a 12-h overnight fast, all subjects underwent a PET imaging protocol (starting at 8:00 AM) to measure myocardial blood flow; myocardial oxygen consumption; myocardial glucose uptake and utilization; and myocardial fatty acid uptake, utilization, and oxidation.
|
|

View larger version (17K):
[in a new window]
|
Figure 2 Myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy (IDCM). Patients with IDCM exhibited significantly lower rates of myocardial fatty acid utilization and myocardial fatty acid oxidation and significantly higher rates of myocardial glucose utilization compared with normal subjects.
|
|
Copyright © 2002 by the American College of Cardiology Foundation.